* ' PTO/SB/30 (08-03)
Approved for use through 07/31/2006. OMB 0651-0031
U.S. Patent and Trademark Office: U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it displays a valid OMB control number.
JTINUED EXAMINATION (RCE)
commissioner for Patents
P.O. Box 1450
Alexandria, VA 22313-1450
First Named Inventor
Daniel H. Maes
Jiang, Shaojia A.
This is a Request for Continued Examination (RCE) under 37 CFR 1.114 of the above-identified application.
Request for Continued Examination (RCE) practice under 37 CFR 1.114 does not apply to any utility or plant application filed prior to June
8, 1995, or to any design application. See Instruction Sheet for RCEs (not to be submitted to the USPTO ) on page 2.
Submission required under 37 CFR 1.114
Note: If the RCE is proper, any previously filed unentered
and amendments enclosed with the RCE will be entered in the order in which they were filed unless applicant instructs otherwise. If
applicant does not wish to have any previously filed unentered amendment(s) entered, applicant must request non-entry of such
Previously submitted. If a final Office action is outstanding, any amendments filed after the final
Office action may be considered as a submission even if this box is not checked.
□ Consider the arguments in the Appeal Brief or Reply Brief previously filed on
□ Affidavits )/Declaration(s)
Information Disclosure Statement (IDS)
a- □ Suspension of action on the above-identified application is requested under 37 CFR 1.103(c) for
a period of months. (Period of suspension shall not exceed 3 months; Fee under 37 CFR 1.1 7(i) required)
b. □ Other
3. | Fees | The RCE fee under 37 CFR 1.17(e) is required by 37 CFR 1.114 when the RCE is filed.
Kl The Director is hereby authorized to charge the following fees, or credit any overpayments, to
Deposit Account No. 05-1320 ;
H RCE fee required under 37 CFR 1 .1 7(e) E 01/08/2004 HAHHED1 00000081 051320 09773351
S Extension of time fee (37 cfr 1.136 and 1.17) 01 FC'1801 770 00 Dft
3 Other any additional fee required
Check in the amount of $
c □ Payment by credit card (Form pto-2038 enclosed) j
WARNING: Information on this form may become public. Credit card information should not
be included on this form. Provide credit card information and authorization on PTO-2038.
SIGNATURE OF APPLICANT, ATTORNEY, OR AGENT REQUIRED
Dorene M. Price
Registration No. (Attorney /Agent)
CERTIFICATE OF MAILING OR TRANSMISSION
I hereby certify that this correspondence is being deposited with the United States Postal Service with sufficient postage as first class mail in
an envelope addressed to: Mail Stop RCE, Commissioner For Patents, P.d. Box 1450, Alexandria, VA 22313-1450 or facsimile transmitted to
the U.S. Patent andTrademark Office on the date shown below. |
Name (Print /Type)
Dorene M. Price
This collection of information is required by 37 CFR 1.114. The information is required to obtain or retain a benefit by the publi?which is to file (and by the USPTO to
process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.14. This collection is estimated to take 12 minutes to complete, including
gathering, preparing, and submitting the completed application form to the USPTO. Time will vary depending upon the individual case. Any comments on the amount
of time you require to complete this form and/or suggestions for reducing the burden, should be sent to the Chief information Officer, U.S. Patent and Trademark
Office, U.S. Department of Commerce, P.O. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND FEES OR COMPLETED FORMS TO THIS ADDRESS SEND
TO: Mail Stop RCE,Commissioner for Patents, P.O. Box 1450, Alexandria, VA 22313-1450.
If you need assistance in completing the form, call 1-800-PTO-9199 and select option 2.
\ Mtfrtey Docket No.: 00.22US
re Application of: Maes, et al.
IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
Group Art Unit: 1617
Filed: January 31, 2001
Examiner: Jiang, Shaojia A.
For: Cholesterol Sulfate and Amino Sugar Compositions for Enhancement of Stratum Corneum Function
Assistant Commissioner of Patents and Trademarks
Washington, D.C. 20231
The following Preliminary Amendment is submitted with a Request for Continued Examination and
as a further response to the Final Office Action dated May 6, 2003 and the Advisory Action dated February
26, 2001. Applicants filed on November 6, 2003 a Notice of Appeal. It is requested in the present
submission that the following remarks be considered with respect to the subject matter of the claims and the
amendments be entered.
RESPONSE PURSUANT TO 37 CFR 1.114